Nelson, Van Denburg & Campbell Wealth Management Group, LLC Allovir, Inc. Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.42 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Apr 30, 2024	BUY	$0.64 - $0.78 $5 - $7	9 New	9 $0

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

Eco R1 Capital, LLC San Francisco, CA

11.3M
Shares

$6.21 Million
0.4% of portfolio
Octagon Capital Advisors LP New York, NY

11.2M
Shares

$6.16 Million
2.19% of portfolio
Siren, L.L.C. New York, NY

6.6M
Shares

$3.63 Million
0.27% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.28M
Shares

$1.81 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.65M
Shares

$1.46 Million
0.0% of portfolio

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $51.2M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account